Emerald Advisers’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,224
Closed -$429K 252
2025
Q4
$429K Sell
4,224
-190
-4% -$15.3K 0.01% 182
2025
Q3
$241K Sell
4,414
-647
-13% -$32.3K 0.01% 220
2025
Q2
$269K Buy
5,061
+94
+2% +$4.78K 0.01% 209
2025
Q1
$215K Sell
4,967
-279
-5% -$14.1K 0.01% 201
2024
Q4
$295K Buy
5,246
+12
+0.2% +$747 0.01% 204
2024
Q3
$357K Sell
5,234
-129
-2% -$7.28K 0.01% 194
2024
Q2
$227K Buy
+5,363
New +$295K 0.01% 205
2021
Q3
Sell
-2,233
Closed -$278K 258
2021
Q2
$278K Hold
2,233
0.01% 221
2021
Q1
$294K Sell
2,233
-80
-3% -$11K 0.01% 221
2020
Q4
$306K Buy
+2,313
New +$280K 0.01% 217
2018
Q4
Sell
-10,822
Closed -$854K 253
2018
Q3
$854K Sell
10,822
-2,291
-17% -$149K 0.03% 188
2018
Q2
$784K Sell
13,113
-388,249
-97% -$20.9M 0.03% 192
2018
Q1
$16.2M Sell
401,362
-13,808
-3% -$674K 0.65% 64
2017
Q4
$21.8M Buy
+415,170
New +$22.2M 0.84% 44
2013
Q3
Sell
-481,890
Closed -$6.7M 348
2013
Q2
$6.7M Buy
+481,890
New +$5.23M 0.41% 80

Other funds holding EXAS

Emerald Advisers's EXAS Position: Q1 2026 in Review

Emerald Advisers sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 4,224 shares — an estimated $429K sold.

Emerald Advisers first reported a position in EXAS in Q2 2013 and held it in 15 quarters. The position peaked at $21.8M in Q4 2017. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Emerald Advisers reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Emerald Advisers sold 4,224 Exact Sciences shares in Q1 2026, an estimated $429K.
  • Emerald Advisers first reported a position in Exact Sciences in Q2 2013 and held it in 15 quarters.
  • Emerald Advisers's Exact Sciences position peaked at $21.8M in Q4 2017.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Emerald Advisers's 13F filing for Q1 2026, filed 4 May 2026.